Dermal Cell News Volume 11.11 | Jun 30 2025

    0
    45







    2025-06-30 | DCN 11.11


    Dermal Cell News by STEMCELL Technologies
    Vol. 11.11 – 30 June, 2025
    TOP STORY

    RIPK4 Promotes Epidermal Differentiation through Phase Separation and Activation of LATS1/2

    Researchers identified receptor-interacting serine/threonine kinase 4 (RIPK4) as an alternative upstream kinase of LATS1/2 in the Hippo pathway through screening a kinome library.
    [Developmental Cell]

    AbstractGraphical Abstract
    Scientific resources to support your cancer research. Learn More!
    PUBLICATIONSListed by the impact factor of the journal

    Exploring the Role of Infected Keratinocytes during Rabies Virus Infection

    The authors investigated the involvement of epidermal keratinocytes in rabies virus (RABV) entry. RABV antigen was detected in keratinocytes at inoculation sites in experimentally infected mice and at potential viral entry sites in naturally infected dogs.
    [npj Viruses]

    Full Article

    Receptor Tyrosine Kinase Inhibitor Tivozanib Regulates Cell State Plasticity and Restores MITF Dependency in BRAF Wild-Type Melanoma

    Scientists evaluated TT-012 and found that most BRAFWT melanoma lines are resistant to TT-012 due to low microphthalmia transcription factor (MITF) transcriptional activity and reduced dependency on MITF for proliferation.
    [Acta Pharmacologica Sinica]

    Abstract

    Dendritic atoh1a+ Cells Serve As Merkel Cell Precursors during Skin Development and Regeneration

    Investigators established that dendritic Merkel cells express atonal homolog 1a (atoh1a), extend dynamic filopodial processes, and arise in transient waves during zebrafish skin development and regeneration.
    [Development]

    Full Article

    Uncovering Minimal Pathways in Melanoma Initiation

    Scientists showed that similar tumors can arise in albino mice bearing only a Braf mutation. Incidence kinetics suggested a stochastic event underlies tumorigenesis in tumors that arise with only a Braf mutation.
    [Nature Communications]

    Full Article

    CDKL3 Targets ATG5 to Exacerbate the Progression of Malignant Melanoma

    The expression of CDKL3 was revealed using clinical human malignant melanoma tissues and normal skin tissues.
    [Molecular Carcinogenesis]

    Abstract
    Request your free copy of the 'Growing Organoids from Stem Cells' Wallchart
    REVIEWS

    An Evaluation of Nivolumab and Ipilimumab for the Treatment of Resectable Stage III Melanoma

    The authors contextualize the emergence of ipilimumab and nivolumab in the adjuvant and neo-adjuvant treatment of resectable stage III melanoma with discussion of pivotal studies, and how they influence the current guidelines.
    [Expert Review of Anticancer Therapy]

    Full Article
    INDUSTRY AND POLICY NEWS

    Scinai Highlights Award-Winning Science behind PC111 as Key Pincell Researcher Receives “Oscar of Italian Dermatology”

    Scinai Immunotherapeutics Ltd. announced that Dr. Roberta Lotti has received the prestigious “Oscar of Italian Dermatology” from SIDeMaST, the Italian Society of Dermatology and Venereology.
    [Scinai Immunotherapeutics Ltd.]

    Press Release
    FEATURED EVENT

    4th Process Development for Cell Therapies Summit

    July 15-17, 2025
    Boston, Massachusetts, United States

    > See All Events

    JOB OPPORTUNITIES

    Laboratory Manager – Skin-Brain Axis

    Howard Hughes Medical Institute (HHMI) – New York City, New York, United States

    Research Assistant – Melanoma

    Edith Cowan University – Joondalup, Australia

    Research Technician – Melanocyte Heterogeneity

    The Ohio State University – Columbus, Ohio

    Postdoctoral Fellow – Melanoma and Multiple Myeloma Biology

    Duke University – Durham, North Carolina, United States

    Postdoctoral Research Fellow – Wound Healing

    University of British Columbia – Vancouver, British Columbia, Canada

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2